IPSC vs MKTX · rev $6.6M vs P/E 13, rev $817.1M
Century Therapeutics Inc (IPSC) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
IPSC currently screens at market cap $47.8M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the IPSC and MKTX stock pages for the full models.
Not investment advice.